Avila Therapeutics - Ownership and Business Overview

Medical ProductsCompany

Avila Therapeutics Ownership

Who owns Avila Therapeutics?

Avila Therapeutics is owned by Celgene. It was acquired on January 26, 2012.

Avila Therapeutics Business Overview

Where is Avila Therapeutics headquartered?

Avila Therapeutics is headquartered in Waltham, Massachusetts.

What sector is Avila Therapeutics in?

Avila Therapeutics is a medical products company.

When was Avila Therapeutics founded?

Avila Therapeutics was founded in 2006.

Medical Products M&A Summary in 2012

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2012. The largest medical products acquisition in 2012 was Pharmaco Hf. - which was acquired by Watson Pharmaceuticals for $4.8B.

Join Mergr to view all 194 acquisitions of medical products companies in 2012, including 29 acquisitions by private equity firms, and 165 by strategics.

Avila Therapeutics, Inc.

100 Beaver Street,
Waltham, Massachusetts 02453
United States,
(781)891-0086
www.avilatx.com

Avila Therapeutics is a clinical-stage biotechnology company focused on the design and development of targeted covalent drugs to achieve best-in class outcomes. The company’s product pipeline has been built using its proprietary Avilomics™ platform and is currently focused on cancer, viral infection and autoimmune disease.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.